Skip to content

CPAP In-home Assessment USA

CPAP In-home Assessment USA

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02809859
Enrollment
139
Registered
2016-06-22
Start date
2016-07-31
Completion date
2017-04-30
Last updated
2019-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Brief summary

The study is to evaluate the product reliability, therapy effectiveness and user feedback of a Continuous Positive Airway Pressure (CPAP) device in-home for up to 6 months.

Detailed description

Existing and Naïve CPAP users will be recruited into a 6 month in-home study Participants will attend 5 study visits at day 0, 7, 30, 60 and 180. Outcome of the clinical investigation include downloadable device data reports, device error reports and participants perception questionnaires.

Interventions

Fisher & Paykel Healthcare CPAP Device

Sponsors

Fisher and Paykel Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged 22 and over * Diagnosed with Obstructive Sleep Apnea (OSA) and prescribed Positive Airway Pressure (either Continuous positive airway pressure (CPAP) or AutoCPAP) * For experienced users of PAP (CPAP or AutoCPAP) - you must be using PAP of more than 4 hours/night for 70% during the last 30 days.

Exclusion criteria

* Contraindicated for PAP (CPAP or AutoCPAP) therapy * Has other significant sleep disorders (e.g periodic leg movements, insomnia, central sleep apnea) * Has obesity hypoventilation syndrome or congestive heart failure * Requires supplemental oxygen with their PAP (CPAP or AutoCPAP) device * Has implanted electronic medical devices (e.g cardiac pacemakers) * Pregnant or think they may be pregnant * Not fluent in spoken and written English.

Design outcomes

Primary

MeasureTime frame
Apnea Hypopnea Index (AHI), Measured as Number of Events/Hour.6 months
Log of Safety Related Events, Measured as Number of Participants That Experienced Unacceptable Safety Related Faults6 months
Machine Reported Faults, Measured as Number of Patients With Machine Faults6 months
Participant Reported Faults, Measured as Number of Participant Complaints6 months

Secondary

MeasureTime frame
How Many Participants Slept Acceptably, Well or Very Well Throughout the Night on the CPAP Device6 months

Countries

United States

Participant flow

Participants by arm

ArmCount
Investigational CPAP Device
Fisher & Paykel Healthcare CPAP Device Fisher & Paykel Healthcare CPAP Device: Fisher & Paykel Healthcare CPAP Device
139
Total139

Baseline characteristics

CharacteristicInvestigational CPAP Device
Age, Continuous55.5 years
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
50 Participants
Sex: Female, Male
Male
89 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
1 / 139
other
Total, other adverse events
0 / 139
serious
Total, serious adverse events
2 / 139

Outcome results

Primary

Apnea Hypopnea Index (AHI), Measured as Number of Events/Hour.

Time frame: 6 months

ArmMeasureValue (MEAN)Dispersion
Investigational CPAP DeviceApnea Hypopnea Index (AHI), Measured as Number of Events/Hour.1.9 events/hrStandard Deviation 2.9
Primary

Log of Safety Related Events, Measured as Number of Participants That Experienced Unacceptable Safety Related Faults

Time frame: 6 months

ArmMeasureValue (NUMBER)
Investigational CPAP DeviceLog of Safety Related Events, Measured as Number of Participants That Experienced Unacceptable Safety Related Faults0 participants
Primary

Machine Reported Faults, Measured as Number of Patients With Machine Faults

Time frame: 6 months

ArmMeasureValue (NUMBER)
Investigational CPAP DeviceMachine Reported Faults, Measured as Number of Patients With Machine Faults3 participants
Primary

Participant Reported Faults, Measured as Number of Participant Complaints

Time frame: 6 months

ArmMeasureValue (NUMBER)
Investigational CPAP DeviceParticipant Reported Faults, Measured as Number of Participant Complaints9 complaints
Secondary

How Many Participants Slept Acceptably, Well or Very Well Throughout the Night on the CPAP Device

Time frame: 6 months

ArmMeasureValue (NUMBER)
Investigational CPAP DeviceHow Many Participants Slept Acceptably, Well or Very Well Throughout the Night on the CPAP Device134 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026